Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the Effect of Subcutaneous Heparin Injection on Pain Intensity and Bruising Incidence
TCTR20160221001Phase 1Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Mar 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1 trial of heparin, sponsored by Mashhad University of Medical Sciences. Primary endpoints: Injection-site pain intensity and Injection-site bruising incidence. Started Mar 2016; status: completed.
02
Drugs
heparin
Beyond the preview
Go deeper on TCTR20160221001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20160221001.